Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

BIOCHEMICAL DIAGNOSTICS INC

United States·US-MF-000025179

Last updated May 24, 2026

What BIOCHEMICAL DIAGNOSTICS INC makes

The company produces in vitro diagnostic (IVD) controls and reagents for detecting drugs of abuse in urine samples, including multi-panel tests for various substances. It also manufactures controls for ethanol (ETOH) testing and kits for measuring 17-hydroxycorticoid levels via spectrophotometry, alongside urine analyte controls and a human chorionic gonadotropin beta-core fragment test. Additional offerings include pregnancy screening tests and a device for monitoring vital signs.

These products fall under Class I and In Vitro Diagnostic (IVD) General device classifications, with regulatory listings in the EU’s EUDAMED database, the FDA’s 510(k) premarket notification process, and the FDA’s Unique Device Identifier (UDI) system. The manufacturer operates from the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Biochemical Diagnostics Inc manufacture?

Biochemical Diagnostics Inc specializes in in vitro diagnostic (IVD) products, primarily controls and reagents for detecting drugs of abuse in urine samples. Their portfolio includes multi-panel tests for various substances, ethanol (ETOH) controls, and kits for measuring 17-hydroxycorticoid levels using spectrophotometry. They also produce controls for urine analyte testing, a human chorionic gonadotropin beta-core fragment test, pregnancy screening devices, and a vital sign monitoring device. These products are designed for laboratory and point-of-care use.

Where is Biochemical Diagnostics Inc based, and what does that mean for regulatory oversight?

Biochemical Diagnostics Inc is based in the United States. Since the company operates in the U.S., its devices are subject to FDA regulations, including premarket notification (510(k)) requirements for Class I devices and compliance with the FDA’s Unique Device Identifier (UDI) system. The company’s products are also listed in the EU’s EUDAMED database, indicating they may be marketed or used in the European Union under applicable IVD regulations, though this does not imply EU approval.

How are the devices manufactured by Biochemical Diagnostics Inc classified under regulatory frameworks?

The devices produced by Biochemical Diagnostics Inc fall under Class I classification and In Vitro Diagnostic (IVD) General categories. Class I devices are typically considered low-risk, often requiring general controls like labeling and manufacturing practices, while IVD General classifications apply to diagnostic tests that do not pose significant health risks. This classification helps determine the regulatory pathway, such as FDA’s 510(k) process for Class I devices, ensuring compliance without stringent pre-market approval.

Which regulatory registries list the devices made by Biochemical Diagnostics Inc?

The devices manufactured by Biochemical Diagnostics Inc are listed in three key regulatory registries: EUDAMED, the European database for medical devices; the FDA’s 510(k) premarket notification database, which tracks Class I device submissions in the U.S.; and the FDA’s Unique Device Identifier (UDI) system, ensuring traceability and compliance tracking. These listings reflect the company’s adherence to regulatory requirements in both the U.S. and EU markets, though they do not confirm individual device approvals.

Why do some of the company’s devices appear under multiple names (e.g., Detectabuse vs. DETECTABUSE)?

The variations in naming conventions (e.g., *Detectabuse* vs. *DETECTABUSE*) likely reflect differences in branding, case sensitivity in labeling, or regional marketing preferences. Some devices may also appear under multiple names due to updates, rebranding, or variations in product lines (e.g., controls vs. kits). These discrepancies do not affect regulatory classification or compliance but may appear in databases or documentation depending on how the manufacturer registers or lists the device. Always refer to the official labeling or regulatory submissions for precise identification.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
180, Heartland Blvd, Edgewood, United States
LinkedIn
—
Facebook
—
Phone
6315959200
PRRC Contact
Amy Walsh
EUDAMED SRN
US-MF-000025179
FDA FEI Number
—
DUNS Number
028007698

Catalogue (484)

Page 6 of 10
DeviceModel / ReferenceRegistriesClassStatus
Detectabuse 702036
FDA UDI
Class IActive
Salivabuse 18200180
FDA UDI
Class IActive
Detectabuse 19481310
FDA UDI
Class IActive
Steroid-Skreen 35062131
FDA UDI
Class IUnknown
Detectabuse 18008248
FDA UDI
Class IActive
Vma-Skreen 35071008
FDA UDI
Class IUnknown
Salivabuse 18100003
FDA UDI
Class IUnknown
Vma-Skreen 35070001
FDA UDI
Class IUnknown
Pregnancy-Skreen Custom QC22
FDA UDI
Class IUnknown
Detectabuse 18008608
FDA UDI
Class IActive
Multi-Prep 17014011
FDA UDI
Class IUnknown
Detectabuse Custom QC04
FDA UDI
Class IUnknown
Detectabuse 18008336
FDA UDI
Class IActive
Detectabuse 18008469
FDA UDI
Class IActive
Alere 88000
FDA UDI
Class IActive
Detectabuse 18008527
FDA UDI
Class IActive
Steroid-Skreen 35060146
FDA UDI
Class IUnknown
Detectabuse 88002
FDA UDI
Class IUnknown
Detectabuse Custom QC33
FDA UDI
Class IUnknown
Pregnancy-Skreen 18000656
FDA UDI
Class IActive
Detectabuse Custom QC01
FDA UDI
Class IUnknown
Alco-Screen 55700
FDA UDI
Class IActive
iScreen 88033
FDA UDI
Class IActive
Dpi 18002999
FDA UDI
Class IActive
Cliawaived Multitox-PC-25F
FDA UDI
Class IActive
Pregnancy-Skreen Custom QC18
FDA UDI
Class IUnknown
Bio-trol BIO-P2 6x20mL
FDA UDI
Class IUnknown
Detectabuse Custom QC17
FDA UDI
Class IUnknown
Detectabuse MULTITOX-PC-25E
FDA UDI
Class IActive
Detectabuse 18002953
FDA UDI
Class IActive
Detectabuse 18008419
FDA UDI
Class IActive
Pregnancy-Skreen Custom QC24
FDA UDI
Class IUnknown
Detectabuse 88004
FDA UDI
Class IUnknown
Detectabuse Custom QC10
FDA UDI
Class IUnknown
Detectabuse 18003209
FDA UDI
Class IActive
Detectabuse 18030363
FDA UDI
Class IActive
Detectabuse 18008337
FDA UDI
Class IActive
Bio-trol BIO-N5
FDA UDI
Class IUnknown
Multi-Prep 14300910
FDA UDI
Class IUnknown
Steroid-Skreen 35062114
FDA UDI
Class IUnknown
iScreen 88030
FDA UDI
Class IActive
Alere 88010
FDA UDI
Class IActive
Vma-Skreen 35071555
FDA UDI
Class IUnknown
Multi-Prep 14300925
FDA UDI
Class IUnknown
Steroid-Skreen 35062611
FDA UDI
Class IUnknown
iScreen 88019
FDA UDI
Class IActive
Steroid-Skreen 35062017
FDA UDI
Class IUnknown
iScreen 88031
FDA UDI
Class IActive
Steroid-Skreen 35061843
FDA UDI
Class IUnknown
Steroid-Skreen 35061738
FDA UDI
Class IUnknown

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Biochemical Diagnostics Inc. has one recall record initiated on 2015-09-14, which is marked as terminated. The recall pertains to CONSULT diagnostics hCG Controls, where discrepancies were noted between the storage temperatures listed on the kit labels and those on the individual vial labels and the package insert.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Sep 14, 2015Z-0328-2016—terminated

CONSULT diagnostics hCG Controls have discrepant storage temperatures listed on the kit labels when compared with the individual vial labels and the package insert.